BYG MED THEILL IVS: Financial statements 2019
CVR: 36023848
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
BYG MED THEILL IVS (CVR 36023848) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2019 report amounted to DKK 0.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 0
- Total Assets
- DKK 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 0 | 0 | 0 | 0 | - |
| 2018 | 0 | 0 | 0 | 0 | - |
| 2017 | 0 | 0 | 0 | 0 | - |
| 2016 | 0 | 0 | 0 | 0 | - |
| 2015 | 28K | 24 | 24 | 24 | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
BYG MED THEILL IVS has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK 0.
About BYG MED THEILL IVS
BYG MED THEILL IVS was a Danish company of the type Iværksætterselskab based in Tommerup, founded in 2014. The company has been dissolved on 21 April 2022. The company was registered under the industry Murere. In 2020, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2020 report amounted to DKK 0.
